Compare PRAX & AFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRAX | AFG |
|---|---|---|
| Founded | 2015 | 1872 |
| Country | United States | United States |
| Employees | N/A | 8700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 11.1B |
| IPO Year | 2020 | N/A |
| Metric | PRAX | AFG |
|---|---|---|
| Price | $331.79 | $130.74 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 4 |
| Target Price | ★ $572.13 | $141.00 |
| AVG Volume (30 Days) | 345.8K | ★ 377.8K |
| Earning Date | 05-01-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.69% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6,395.88 | $4.61 |
| P/E Ratio | ★ N/A | $12.86 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $28.79 | $120.52 |
| 52 Week High | $354.87 | $150.02 |
| Indicator | PRAX | AFG |
|---|---|---|
| Relative Strength Index (RSI) | 57.17 | 55.63 |
| Support Level | $282.49 | $129.99 |
| Resistance Level | $327.65 | $134.17 |
| Average True Range (ATR) | 17.60 | 2.51 |
| MACD | 2.86 | 0.54 |
| Stochastic Oscillator | 81.68 | 66.17 |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
American Financial Group Inc is an insurance holding company. Through its subsidiaries, it is engaged in the property and casualty insurance business, focusing on specialized commercial products for businesses. The group operates through two segments: Property and Casualty Insurance, which generates maximum revenue, and Other. The Property and Casualty Insurance segment is further divided into different sub-segments, such as Property and transportation, Specialty casualty, and Specialty financial. These sub-segments offer insurance coverage for vehicles and commercial property, customized programs for small to mid-sized businesses, workers' compensation insurance, risk management insurance programs for lending and leasing institutions, trade credit insurance, and other insurance products.